September 20- Daily Update – SRPT

Obviously the big news of the day was the failure of drisapersen in their phase III trial and what it means for etperlirsen and SRPT. While it is not clear.

September 19- EOD

It was a relatively quiet news day. I was not sure there would be much to write about and there is nothing really new or compelling. There are some quick.

September 18- EOD

It was Fed day today, so the market was very macro driven in terms of price action. The Bernank doubled down on easing, which was a good macro environment. That.

September 18- EOD

It was Fed day today, so the market was very macro driven in terms of price action. The Bernank doubled down on easing, which was a good macro environment. That.

September 18- EOD

It was Fed day today, so the market was very macro driven in terms of price action. The Bernank doubled down on easing, which was a good macro environment. That.

September 17- EOD

Not a lot of stock specific news but some interesting larger biotech developments. The market held up better than I thought given yesterday’s close and biotechs seemed like slight underperformers.

September 16- EOD

It was a strong day in the market but a weak day in biotech. That being said I think there was a definite pattern in that the large caps and.

September 16- EOD

It was a strong day in the market but a weak day in biotech. That being said I think there was a definite pattern in that the large caps and.

September 16- EOD

It was a strong day in the market but a weak day in biotech. That being said I think there was a definite pattern in that the large caps and.

September 13- EOD

Generally a mixed day in biotech land today with some interesting stock specific moves but nothing really dramatic in terms of news. Looks like a quiet end to the week.

September 12- EOD

Another relatively weak day in biotech land but this is not to say that the market in general was particularly strong. It is not surprising that both the market and.

September 12- EOD

Another relatively weak day in biotech land but this is not to say that the market in general was particularly strong. It is not surprising that both the market and.

September 12- EOD

Another relatively weak day in biotech land but this is not to say that the market in general was particularly strong. It is not surprising that both the market and.

September 11- Morning

This is both an early and short report for today as I am on sick child duty for the day. Luckily it was not a particularly newsy morning and if.

SGMO – Abstracts

The SGMO ICAAC abstracts are now available. This links to the late breaker abstract. Abstract: Background: Expression of CCR5 by CD4 cells is necessary for productive R5 HIV infection. Biallelic.

September 10- EOD

Decent day in the market but biotechs did not seem to participate to the same extent. Of course, I do not have much time to follow the market on Tuesday.

September 9- EOD

Some interesting news today and generally a positive market environment, although some of the recent high fliers seemed to take most of the day off. That is not completely surprising.

September 6- EOD

The week ended with some interesting action and volatility over Syria news. The markets appear jumpy but note that the sell off was over the words of Putin. I think.

September 6- EOD

The week ended with some interesting action and volatility over Syria news. The markets appear jumpy but note that the sell off was over the words of Putin. I think.

September 6- EOD

The week ended with some interesting action and volatility over Syria news. The markets appear jumpy but note that the sell off was over the words of Putin. I think.

Browsing 20 / articles